Elsie Oppermann

Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities

Anja Mottok, Christoph Renné, Marc Seifert et al. · Blood · 2009 · 123 citations · Full text

Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells

Roman A. Blaheta, Kerstin Leckel, Bianca M. Wittig et al. · Transplantation Proceedings · 1999 · 92 citations

Cell Therapy, Mycophenolate Mofetil, Transplantation +14

CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study

Igor Tsaur, Anika Noack, Jasmina Makarević et al. · Cancer Research and Treatment · 2014 · 58 citations · Full text

Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil

Roman A. Blaheta, Kerstin Leckel, Bianca M. Wittig et al. · Transplant Immunology · 1998 · 53 citations

Inflammation, Mycophenolate Mofetil, Signal Transduction +10

Characterization of Bone Marrow Mononuclear Cells on Biomaterials for Bone Tissue Engineering<i>In Vitro</i>

Dirk Henrich, René D. Verboket, Alexander Schaible et al. · BioMed Research International · 2015 · 43 citations · Full text

Tissue Engineering, Engineering, Multifunctional Biomaterials +23